Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding
Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding
Respiratory diseases account for over 5 million deaths yearly and are a huge burden to health-care systems worldwide. Murine models have been of paramount importance to decode human lung biology in vivo, but their genetic, anatomical, physiological and immunological differences with humans significantly hamper successful translation of research into clinical practice. Thus, to clearly understand human lung physiology, development, homeostasis and mechanistic dysregulation that may lead to disease, it is essential to develop models that accurately recreate the extraordinary complexity of the human pulmonary architecture and biology. Recent advances in micro-engineering technology and tissue engineering have allowed the development of more sophisticated models intending to bridge the gap between the native lung and its replicates in vitro Alongside advanced culture techniques, remarkable technological growth in downstream analyses has significantly increased the predictive power of human biology-based in vitro models by allowing capture and quantification of complex signals. Refined integrated multi-omics readouts could lead to an acceleration of the translational pipeline from in vitro experimental settings to drug development and clinical testing in the future. This review highlights the range and complexity of state-of-the-art lung models for different areas of the respiratory system, from nasal to large airways, small airways, and alveoli, with consideration of various aspects of disease states and their potential applications, including pre-clinical drug testing. We explore how development of optimised physiologically relevant in vitro human lung models could accelerate the identification of novel therapeutics with increased potential to translate successfully from the bench to the patient's bedside.
Humbert, Maria Victoria
82134d25-24b8-4fdd-bd1c-461683b5322e
Spalluto, Cosma Mirella
6802ad50-bc38-404f-9a19-40916425183b
Bell, Joseph
9ce5c105-543f-40c2-883a-26643c194638
Blume, Cornelia
aa391c64-8718-4238-906b-d6bb1551a07b
Conforti, Franco
28bf123c-e42a-4fb5-8b26-f79e1095c586
Davies, Elizabeth R
2e6920ea-b7ce-46e3-918c-5a2095e8e4d2
Dean, Lareb S N
41e0c113-ad78-425f-a9dc-60081f8f0027
Elkington, Paul
60828c7c-3d32-47c9-9fcc-6c4c54c35a15
Haitchi, Hans Michael
68dadb29-305d-4236-884f-e9c93f4d78fe
Jackson, Claire
64cdd6fa-74c3-4ac6-94ef-070620a6efd9
Jones, Mark G
2e377517-5b32-464c-98ff-93875459644e
Loxham, Matthew
8ef02171-9040-4c1d-8452-2ca34c56facb
Lucas, Jane S
5cb3546c-87b2-4e59-af48-402076e25313
Morgan, Hywel
de00d59f-a5a2-48c4-a99a-1d5dd7854174
Polak, Marta
e0ac5e1a-7074-4776-ba23-490bd4da612d
Staples, Karl J
e0e9d80f-0aed-435f-bd75-0c8818491fee
Swindle, Emily J
fe393c7a-a513-4de4-b02e-27369bd7e84f
Tezera, Liku
c5598dbf-23a8-4934-96a4-7c783bf9e776
Watson, Alastair
9eb79329-8d32-4ed4-b8b9-d720883e8042
Wilkinson, Tom M A
9c51b529-00ce-45d2-b6e0-b623f61fdf82
1 December 2022
Humbert, Maria Victoria
82134d25-24b8-4fdd-bd1c-461683b5322e
Spalluto, Cosma Mirella
6802ad50-bc38-404f-9a19-40916425183b
Bell, Joseph
9ce5c105-543f-40c2-883a-26643c194638
Blume, Cornelia
aa391c64-8718-4238-906b-d6bb1551a07b
Conforti, Franco
28bf123c-e42a-4fb5-8b26-f79e1095c586
Davies, Elizabeth R
2e6920ea-b7ce-46e3-918c-5a2095e8e4d2
Dean, Lareb S N
41e0c113-ad78-425f-a9dc-60081f8f0027
Elkington, Paul
60828c7c-3d32-47c9-9fcc-6c4c54c35a15
Haitchi, Hans Michael
68dadb29-305d-4236-884f-e9c93f4d78fe
Jackson, Claire
64cdd6fa-74c3-4ac6-94ef-070620a6efd9
Jones, Mark G
2e377517-5b32-464c-98ff-93875459644e
Loxham, Matthew
8ef02171-9040-4c1d-8452-2ca34c56facb
Lucas, Jane S
5cb3546c-87b2-4e59-af48-402076e25313
Morgan, Hywel
de00d59f-a5a2-48c4-a99a-1d5dd7854174
Polak, Marta
e0ac5e1a-7074-4776-ba23-490bd4da612d
Staples, Karl J
e0e9d80f-0aed-435f-bd75-0c8818491fee
Swindle, Emily J
fe393c7a-a513-4de4-b02e-27369bd7e84f
Tezera, Liku
c5598dbf-23a8-4934-96a4-7c783bf9e776
Watson, Alastair
9eb79329-8d32-4ed4-b8b9-d720883e8042
Wilkinson, Tom M A
9c51b529-00ce-45d2-b6e0-b623f61fdf82
Humbert, Maria Victoria, Spalluto, Cosma Mirella, Bell, Joseph, Blume, Cornelia, Conforti, Franco, Davies, Elizabeth R, Dean, Lareb S N, Elkington, Paul, Haitchi, Hans Michael, Jackson, Claire, Jones, Mark G, Loxham, Matthew, Lucas, Jane S, Morgan, Hywel, Polak, Marta, Staples, Karl J, Swindle, Emily J, Tezera, Liku, Watson, Alastair and Wilkinson, Tom M A
(2022)
Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding.
The European respiratory journal, 60 (6), [2200455].
(doi:10.1183/13993003.00455-2022).
Abstract
Respiratory diseases account for over 5 million deaths yearly and are a huge burden to health-care systems worldwide. Murine models have been of paramount importance to decode human lung biology in vivo, but their genetic, anatomical, physiological and immunological differences with humans significantly hamper successful translation of research into clinical practice. Thus, to clearly understand human lung physiology, development, homeostasis and mechanistic dysregulation that may lead to disease, it is essential to develop models that accurately recreate the extraordinary complexity of the human pulmonary architecture and biology. Recent advances in micro-engineering technology and tissue engineering have allowed the development of more sophisticated models intending to bridge the gap between the native lung and its replicates in vitro Alongside advanced culture techniques, remarkable technological growth in downstream analyses has significantly increased the predictive power of human biology-based in vitro models by allowing capture and quantification of complex signals. Refined integrated multi-omics readouts could lead to an acceleration of the translational pipeline from in vitro experimental settings to drug development and clinical testing in the future. This review highlights the range and complexity of state-of-the-art lung models for different areas of the respiratory system, from nasal to large airways, small airways, and alveoli, with consideration of various aspects of disease states and their potential applications, including pre-clinical drug testing. We explore how development of optimised physiologically relevant in vitro human lung models could accelerate the identification of novel therapeutics with increased potential to translate successfully from the bench to the patient's bedside.
Text
13993003.00455-2022.full
- Accepted Manuscript
More information
Accepted/In Press date: 11 June 2022
e-pub ahead of print date: 1 July 2022
Published date: 1 December 2022
Additional Information:
Funding Information:
Support statement: The National Institute for Health and Care Research (NIHR) Southampton Biomedical Research Centre (BRC) supported this work.
Publisher Copyright:
©The authors 2022.
Identifiers
Local EPrints ID: 468484
URI: http://eprints.soton.ac.uk/id/eprint/468484
ISSN: 0903-1936
PURE UUID: bc147bd0-f683-4bcf-8eed-e60b617d8819
Catalogue record
Date deposited: 16 Aug 2022 16:44
Last modified: 20 Feb 2025 05:05
Export record
Altmetrics
Contributors
Author:
Maria Victoria Humbert
Author:
Cosma Mirella Spalluto
Author:
Joseph Bell
Author:
Franco Conforti
Author:
Elizabeth R Davies
Author:
Lareb S N Dean
Author:
Claire Jackson
Author:
Mark G Jones
Author:
Hywel Morgan
Author:
Alastair Watson
Author:
Tom M A Wilkinson
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics